摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-chloro-4-(cyclopentyloxy)benzonitrile | 1035217-56-1

中文名称
——
中文别名
——
英文名称
3-chloro-4-(cyclopentyloxy)benzonitrile
英文别名
3-chloro-4-cyclopentyloxybenzonitrile
3-chloro-4-(cyclopentyloxy)benzonitrile化学式
CAS
1035217-56-1
化学式
C12H12ClNO
mdl
——
分子量
221.686
InChiKey
ZQECSPNXWGJZNF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    344.2±22.0 °C(Predicted)
  • 密度:
    1.22±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    33
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-chloro-4-(cyclopentyloxy)benzonitrile 在 aluminum (III) chloride 、 lithium aluminium tetrahydride 、 盐酸 作用下, 以 乙醚二氯甲烷 为溶剂, 反应 19.5h, 以11%的产率得到(3-chloro-4-(cyclopentyloxy)phenyl)methanaminium chloride
    参考文献:
    名称:
    A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
    摘要:
    Recently we reported the discovery of a potent and selective CK2 alpha inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (alpha D pocket). Here we describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy. Specifically, we aimed to develop inhibitors by linking a high-affinity fragment anchored in the alD site to a weakly binding warhead fragment occupying the ATP site. Moreover, we describe the remarkable impact that molecular modelling had on the development of this novel chemical tool. The work described herein shows potential for the development of a novel class of CK2 inhibitors. (C) 2017 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2017.04.037
  • 作为产物:
    描述:
    溴代环戊烷3-氯-4-羟基苯甲腈potassium carbonate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 18.0h, 以89%的产率得到3-chloro-4-(cyclopentyloxy)benzonitrile
    参考文献:
    名称:
    A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066
    摘要:
    Recently we reported the discovery of a potent and selective CK2 alpha inhibitor CAM4066. This compound inhibits CK2 activity by exploiting a pocket located outside the ATP binding site (alpha D pocket). Here we describe in detail the journey that led to the discovery of CAM4066 using the challenging fragment linking strategy. Specifically, we aimed to develop inhibitors by linking a high-affinity fragment anchored in the alD site to a weakly binding warhead fragment occupying the ATP site. Moreover, we describe the remarkable impact that molecular modelling had on the development of this novel chemical tool. The work described herein shows potential for the development of a novel class of CK2 inhibitors. (C) 2017 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmc.2017.04.037
点击查看最新优质反应信息

文献信息

  • ANDROGEN MODULATORS
    申请人:Hu Lain-Yen
    公开号:US20100048517A1
    公开(公告)日:2010-02-25
    The present invention is directed to a new class of 4-cycloalkoxy benzonitriles and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth.
    本发明涉及一种新的4-环烷氧基苯甲腈类化合物,以及它们作为雄激素受体调节剂的用途。本发明的其他方面涉及使用这些化合物来减少多余的皮脂分泌和刺激头发生长。
  • 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF
    申请人:Harada Hironori
    公开号:US20120178735A1
    公开(公告)日:2012-07-12
    Provided is a 2H-chromene compound or a derivative thereof which has an excellent S1P1 agonist action. The 2H-chromene compound or derivative is particularly useful for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells.
    提供了一种2H-色烯化合物或其衍生物,具有优异的S1P1激动剂作用。该2H-色烯化合物或衍生物特别适用于预防和/或治疗由不良淋巴细胞浸润引起的疾病或由细胞异常增殖或堆积引起的疾病。
  • 2H-CHROMENE DERIVATIVES AS STIMULATORS OF SPHINGOSINE 1-PHOSPHATE RECEPTOR
    申请人:Astellas Pharma Inc.
    公开号:EP2354134B1
    公开(公告)日:2016-02-24
  • US7670613B2
    申请人:——
    公开号:US7670613B2
    公开(公告)日:2010-03-02
  • US7834039B2
    申请人:——
    公开号:US7834039B2
    公开(公告)日:2010-11-16
查看更多